Jessica Smith, APRN
Family · Lexington, KYNPI 1376996629
Payments from drug & device makers
Across 126 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$672
- AbbVie$320
- Lilly USA, LLC$276
- Sanofi$259
- UCB, Inc.$223
- E.r. Squibb & Sons, L.L.C.$199
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,53682%
- Education$56018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $672 |
| AbbVie | 18 | $320 |
| Lilly USA, LLC | 15 | $276 |
| Sanofi | 9 | $259 |
| UCB, Inc. | 11 | $223 |
| E.r. Squibb & Sons, L.L.C. | 12 | $199 |
| Incyte Corporation | 4 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Amgen | 5 | $116 |
| Novartis | 5 | $116 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $73 |
| LEO Pharma Inc. | 3 | $73 |
| Pfizer | 3 | $52 |
| Galderma Laboratories, L.p. | 3 | $48 |
| Sun Pharmaceutical Industries Inc. | 2 | $43 |
| Boehringer Ingelheim | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| X4 Pharmaceuticals, Inc. | 1 | $29 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| Dermavant Sciences, Inc. | 1 | $27 |
| Almirall LLC | 1 | $23 |
| Biofrontera Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $17 |
| Organon | 1 | $16 |
How this compares
$3,096 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 23 | $169,507 |
| Dupixent SyringeDupilumab | 12 | $43,918 |
| Ketoconazole | 178 | $2,525 |
| Clobetasol Propionate | 79 | $1,761 |
| Tretinoin | 22 | $1,559 |
| Fluorouracil | 20 | $1,520 |
| Clindamycin Phosphate | 28 | $1,072 |
| Metronidazole | 16 | $791 |
| Triamcinolone Acetonide | 35 | $396 |
| Doxycycline Hyclate | 26 | $387 |
| Hydrocortisone | 95 | $278 |
| Finasteride | 20 | $252 |
| Mometasone Furoate | 18 | $235 |
| Mupirocin | 36 | $208 |
| ValacyclovirValacyclovir Hcl | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other family in Lexington
- Elizabeth SaltLexington$89K
- Alisha ClemonsLexington$55K
- Timothy SmallwoodLexington$27K
- Lauren MaupinLexington$18K
- Angela CrutcherLexington$16K
- Emily MesserliLexington$13K
- Rhiannon BlackLexington$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.